• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Addus HomeCare Corporation filed SEC Form 8-K: Leadership Update

    3/11/25 4:12:41 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care
    Get the next $ADUS alert in real time by email
    8-K
    Addus HomeCare Corp false 0001468328 0001468328 2025-03-10 2025-03-10

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported): March 11, 2025 (March 10, 2025)

     

     

    ADDUS HOMECARE CORPORATION

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-34504   20-5340172

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    6303 Cowboys Way, Suite 600

    Frisco, Texas

        75034
    (Address of principal executive offices)     (Zip Code)

    (469) 535-8200

    (Registrant’s telephone number, including area code)

    N/A

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, $0.001 par value per share   ADUS   The Nasdaq Stock Market, LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company. ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Future Retirement of W. Bradley Bickham as President and Chief Operating Officer

    On March 10, 2025, W. Bradley Bickham notified Addus HomeCare Corporation (the “Company”) of his intent to retire from his position as President and Chief Operating Officer, effective as of March 10, 2026. Mr. Bickham’s retirement is not the result of any disagreement with management, the Company or its operations, policies or practices. A copy of the press release issued by the Company relating to Mr. Bickham’s retirement is attached hereto as Exhibit 99.1 and incorporated herein by reference. In connection with Mr. Bickham’s retirement, Addus HealthCare, Inc., an Illinois corporation and a wholly-owned subsidiary of the Company (“Addus HealthCare”), and Mr. Bickham entered into a Retention and Transition Agreement providing that, in consideration of Mr. Bickham’s continuation of employment through March 10, 2026, Addus HealthCare will cause his then unvested restricted shares of common stock under Restricted Stock Agreements dated February 21, 2025 and February 23, 2024 and February 24, 2023 to vest in full at such date. A copy of the Retention and Transition Agreement is attached hereto as Exhibit 10.1 and incorporated herein by reference.

    Third Amended and Restated Employment Agreement for R. Dirk Allison

    On March 10, 2025, Addus HealthCare entered into a third amended and restated employment and non-competition agreement with R. Dirk Allison, the Company’s Chief Executive Officer and Chairman of the Board (the “Third A&R Employment Agreement”).

    The Third A&R Employment Agreement amends Mr. Allison’s prior employment agreement by providing for a three year employment term beginning on March 10, 2025, for the grant of restricted shares described below, and for certain conforming changes.

    The foregoing description of the Third A&R Employment Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Third A&R Employment Agreement, which is included as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference.

    Grant of Restricted Shares

    The Compensation Committee of the Board of Directors of the Company authorized the Company to grant the following awards of restricted shares of the Company’s common stock to the following executive officers of the Company, which were in addition to awards made under previously disclosed compensation plans, effective March 10, 2025 (the “Grant Date”):

     

    Executive Officer

       Restricted Shares of
    Common Stock
     

    R. Dirk Allison

         63,500  

    Brian Poff

         31,750  

    The restricted shares granted to Messrs. Allison and Poff will vest in full on the third anniversary of the Grant Date, provided that the restricted shares granted to Mr. Allison will become immediately vested upon a change in control, Mr. Allison’s disability or death, the termination of Mr. Allison’s employment by the Company without cause (50% on such termination as Chief Executive Officer), and upon the occurrence of certain circumstances that would allow Mr. Allison to terminate his employment for good reason, and that the restricted shares granted to Mr. Poff will become immediately vested upon a change in control, Mr. Poff’s disability or death, the termination of Mr. Poff’s employment by the Company without cause, and upon the occurrence of circumstances that would allow Mr. Poff to terminate his employment for good reason.


    Item 7.01.

    Regulation FD Disclosure

    On March 11, 2025, the Company issued the Press Release, announcing the matters discussed in Item 5.02, the text of which is set forth as Exhibit 99.1.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits:

     

    Exhibit

    No.

       Description
    10.1    Retention and Transition Agreement, dated March 10, 2025, by and between Addus Healthcare, Inc. and W. Bradley Bickham.
    10.2    Third Amended and Restated Employment and Non-Competition Agreement, dated March 10, 2025, by and between Addus Healthcare, Inc. and R. Dirk Allison.
    99.1    Press Release of Addus HomeCare Corporation dated March 11, 2025.
    104    Cover Page Interactive Data File (embedded within Inline XBRL document).


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        ADDUS HOMECARE CORPORATION
    Date: March 11, 2025     By:  

    /s/ Brian Poff

          Brian Poff
          Chief Financial Officer
    Get the next $ADUS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADUS

    DatePrice TargetRatingAnalyst
    12/16/2024$150.00Mkt Outperform
    JMP Securities
    10/11/2024$150.00Overweight
    KeyBanc Capital Markets
    6/28/2024$136.00Outperform
    Macquarie
    4/23/2024$83.00Equal Weight → Underweight
    Barclays
    3/6/2024$88.00Equal Weight
    Barclays
    2/5/2024Outperform
    William Blair
    12/12/2023$105.00Outperform
    TD Cowen
    6/29/2022$101.00Buy
    Stifel
    More analyst ratings

    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Addus HomeCare to Participate in Upcoming Investor Conferences in May

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securities 2025 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 14, 2025. Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:20 a.m. Pacific Time / 11:20 a.m. Central Time on Wednesday, May 14, 2025. 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025. Dirk Allison, Chairman and Chief Executive Officer and Brian Poff, Executive Vice Pr

      5/6/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • JMP Securities initiated coverage on Addus HomeCare with a new price target

      JMP Securities initiated coverage of Addus HomeCare with a rating of Mkt Outperform and set a new price target of $150.00

      12/16/24 6:21:27 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Addus HomeCare with a new price target

      KeyBanc Capital Markets initiated coverage of Addus HomeCare with a rating of Overweight and set a new price target of $150.00

      10/11/24 7:29:16 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Macquarie initiated coverage on Addus HomeCare with a new price target

      Macquarie initiated coverage of Addus HomeCare with a rating of Outperform and set a new price target of $136.00

      6/28/24 7:30:03 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Addus HomeCare Corporation

      SC 13G - Addus HomeCare Corp (0001468328) (Subject)

      11/13/24 9:44:25 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      2/13/24 4:55:59 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      1/22/24 2:03:09 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    SEC Filings

    See more
    • SEC Form 10-Q filed by Addus HomeCare Corporation

      10-Q - Addus HomeCare Corp (0001468328) (Filer)

      5/6/25 4:30:26 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form 8-K filed by Addus HomeCare Corporation

      8-K - Addus HomeCare Corp (0001468328) (Filer)

      5/5/25 4:54:55 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Corporation filed SEC Form 8-K: Leadership Update

      8-K - Addus HomeCare Corp (0001468328) (Filer)

      3/11/25 4:12:41 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP/Chief Development Officer Blessing Cliff Donald sold $18,008 worth of shares (178 units at $101.17), decreasing direct ownership by 2% to 10,401 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      4/22/25 4:30:22 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • EVP/Chief Financial Officer Poff Brian was granted 31,750 shares, increasing direct ownership by 96% to 64,719 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      3/12/25 4:00:12 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • CEO and Chairman Allison R Dirk was granted 63,500 shares, increasing direct ownership by 62% to 166,461 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      3/12/25 4:00:05 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Leadership Updates

    Live Leadership Updates

    See more
    • Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

      Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. "Axonics is fortunate to have someone of Dr. López's character and extensive experience join our board of directors," said Raymond W. Cohen, CEO of Axonics. "Given his thought leadership in healthcare, Dr. López will be a valuable adviser to Axonics as we continue to execute on our ambitious growth objectives." Dr. López is the Americas healthcare and life sciences Market Lead at Google Cloud with multinational

      7/15/21 6:00:00 AM ET
      $AXNX
      $ADUS
      Medical/Dental Instruments
      Health Care
      Medical/Nursing Services
    • Addus HomeCare Announces Retirement of Laurie Manning

      Robby Stevenson Named Company's Chief Human Resource Officer Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11, 2021. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area. Commenting on the announcement, Dirk Allison, Chairman and Chief Executive Officer, said, "Laurie has played an important role in the growth and success of Addus since she joined the Company in 2017. Our employees are our most impor

      6/14/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Names Veronica Hill-Milbourne And Esteban López, M.D. To Board Of Directors

      FRISCO, Texas, Jan. 11, 2021 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced that Veronica Hill-Milbourne and Esteban López, M.D. have been appointed to the Company's Board of Directors, effective January 11, 2021. Ms. Hill-Milbourne is President and Chief Executive Officer of Spectrum Health Services, Inc., with executive oversight of three Federally Qualified Health Centers located in Philadelphia, Pennsylvania. She previously served as Chief Executive Officer/State Director for Pathways by Atar Capital, with executive oversight of mental and behavioral health home and community-based service programs operating in 30 counties

      1/11/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Financials

    Live finance-specific insights

    See more
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights: Net Service Revenues Grow 7.5% to $297.1 Million Net Income of $19.5 Million, or $1.07 per Diluted Share Adjusted Net Income per Diluted Share Increases 4.6% year-over-year to $1.38 Adjusted EBITDA Increases 10.3% year-over-year to $37.8 Million Cash Flow from Operations of $10.4 Million Completed acquisition of Gentiva personal care operations Overview Net service revenues were $297.1 million for the fourth quarter of 2024, a 7.5% increase compared with $276.4 milli

      2/24/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care